These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26056083)

  • 1. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
    Di Martino MT; Guzzi PH; Caracciolo D; Agnelli L; Neri A; Walker BA; Morgan GJ; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2015 Aug; 6(22):19132-47. PubMed ID: 26056083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Analysis of microRNA in Multiple Myeloma.
    Di Martino MT; Amodio N; Tassone P; Tagliaferri P
    Methods Mol Biol; 2016; 1375():181-94. PubMed ID: 25971914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
    Gao H; Wang H; Yang W
    Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.
    Kassambara A; Jourdan M; Bruyer A; Robert N; Pantesco V; Elemento O; Klein B; Moreaux J
    Nucleic Acids Res; 2017 Jun; 45(10):5639-5652. PubMed ID: 28459970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant microRNA expression in multiple myeloma.
    Dimopoulos K; Gimsing P; Grønbæk K
    Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression.
    Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D
    Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
    Gutiérrez NC; Sarasquete ME; Misiewicz-Krzeminska I; Delgado M; De Las Rivas J; Ticona FV; Fermiñán E; Martín-Jiménez P; Chillón C; Risueño A; Hernández JM; García-Sanz R; González M; San Miguel JF
    Leukemia; 2010 Mar; 24(3):629-37. PubMed ID: 20054351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients.
    Calura E; Bisognin A; Manzoni M; Todoerti K; Taiana E; Sales G; Morgan GJ; Tonon G; Amodio N; Tassone P; Neri A; Agnelli L; Romualdi C; Bortoluzzi S
    Oncotarget; 2016 Jan; 7(3):2367-78. PubMed ID: 26496024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
    Baglìo SR; Devescovi V; Granchi D; Baldini N
    Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of miRNAs as biomarkers for multiple myeloma.
    Rocci A; Hofmeister CC; Pichiorri F
    Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
    Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
    Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
    Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of subtype specific miRNA-mRNA functional regulatory modules in matched miRNA-mRNA expression data: multiple myeloma as a case.
    Zhang Y; Liu W; Xu Y; Li C; Wang Y; Yang H; Zhang C; Su F; Li Y; Li X
    Biomed Res Int; 2015; 2015():501262. PubMed ID: 25874214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.
    Weinhold N; Moreaux J; Raab MS; Hose D; Hielscher T; Benner A; Meissner T; Ehrbrecht E; Brough M; Jauch A; Goldschmidt H; Klein B; Moos M
    Genes Chromosomes Cancer; 2010 Apr; 49(4):333-41. PubMed ID: 20073075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in the pathobiology of multiple myeloma.
    Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
    Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MicroRNA and multiple myeloma].
    Li CM; Chen LJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):244-8. PubMed ID: 21362262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.